Equate Cream
NDC 49035-080
Product Information
Equate (terbinafine hydrochloride) is a ANDA-approved product labeled by Wal-mart Stores Inc. This medication is typically used as a allylamine antifungal [epc]. It is supplied as a white cream for topical administration. This product entry covers the primary NDC 49035-080 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
Code Structure Chart
Product Details
What is NDC 49035-080?
What are the uses of this product?
What are Active Ingredients of this product?
- TERBINAFINE HYDROCHLORIDE 1 g/100g - A naphthalene derivative that inhibits fungal SQUALENE EPOXIDASE and is used to treat DERMATOMYCOSES of the skin and nails.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- TERBINAFINE HYDROCHLORIDE (UNII: 012C11ZU6G)
- TERBINAFINE (UNII: G7RIW8S0XP) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- BENZYL ALCOHOL (UNII: LKG8494WBH)
- CETYL ALCOHOL (UNII: 936JST6JCN)
- CETYL PALMITATE (UNII: 5ZA2S6B08X)
- ISOPROPYL MYRISTATE (UNII: 0RE8K4LNJS)
- POLYSORBATE 60 (UNII: CAL22UVI4M)
- WATER (UNII: 059QF0KO0R)
- SODIUM HYDROXIDE (UNII: 55X04QC32I)
- SORBITAN MONOSTEARATE (UNII: NVZ4I0H58X)
- STEARYL ALCOHOL (UNII: 2KR89I4H1Y)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 992528 - terbinafine HCl 1 % Topical Cream
- RxCUI: 992528 - terbinafine hydrochloride 10 MG/ML Topical Cream
- RxCUI: 992528 - terbinafine hydrochloride 1 % Topical Cream
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.